Search

Hematologic Malignancies | UT Southwestern Medical Center

Lung Cancer | UT Southwestern Medical Center

Patient Care | UT Southwestern Medical Center

Martin Pomper, M.D., Ph.D., Professor and Chair of Radiology at UT Southwestern discusses the evolution of the field and its expanding applications.

Simmons Cancer Center is working to develop supercharged anti-cancer cellular therapies that could cure solid tumors in adult patients.

The Siegwart Lab Program in Genetic Drug Engineering uses nanoparticle technology to create anti-cancer medicines generated within the human body.

The Interventional Pulmonology and Thoracic Surgery teams at Harold C. Simmons Comprehensive Cancer Center are united in a single service line, minimizing the time-to-treatment window from months to two weeks — and, in some cases, as little as 24 hours. Pillars of the program include optimized patient care pathways, research-led technology, and streamlined referral processes.

For years, UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center has been home to two SPOREs, focused on lung and kidney cancers. In September 2025, UT Southwestern was awarded a third SPORE for liver cancer.

The UT Southwestern Harold C. Simmons Comprehensive Cancer Center recognizes the treatment of leukemia, lymphoma, and myeloma as “high performing,” placing UT Southwestern among the nation’s top institutions for this area of care.

Maintenance | UT Southwestern Medical Center